Home / Rivaroxaban / Czechia
CZ ATC B01AF01 · updated 2 Nov 2026
Rivaroxaban shortage in Czechia
Is there a Rivaroxaban shortage in Czechia?
Yes. As of 2 Nov 2026, 6 Rivaroxaban products are reported short in Czechia, the first since 5 Oct 2026. The company estimate for the return is 13 Dec 2026 (latest 6 Jan 2027). Main reason: manufacturing problem.
Also short in United States, Canada, Germany, France, Italy, Spain, Ireland, Austria, Belgium, Switzerland, Sweden, Japan. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | RIVAROXABAN SANDOZ 2,5MG 2,5MG TBL FLM 196 | Sandoz s.r.o., Praha | 5 Oct 2026 | 4 Jan 2027 | Manufacturing problem Výrobní důvody |
| CZ | XARELTO 15MG 15MG TBL FLM 28 II | Bayer AG, Leverkusen | 1 Nov 2026 | 23 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | XARELTO 15MG 15MG TBL FLM 98 II | Bayer AG, Leverkusen | 1 Nov 2026 | 13 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | XARELTO 20MG 20MG TBL FLM 98 II | Bayer AG, Leverkusen | 1 Nov 2026 | 13 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | RIVAROXABAN TEVA 10MG 10MG TBL FLM 30X1 anticipated | Teva Pharmaceuticals CR, s.r.o., Praha | 14 Nov 2026 | 31 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | XARELTO 20MG 20MG TBL FLM 28 II anticipated | Bayer AG, Leverkusen | 22 Nov 2026 | 6 Jan 2027 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.